Brief: Living Cell Technologies Signs MoU With Nzeno, Secures Pig Cells For NTCELL Trial
26/10/2021 02:02
Oct 26 (Reuters) - Living Cell Technologies Ltd LCT.AX :
* SIGNS MOU WITH NZENO, SECURES PIG CELLS FOR NTCELL TRIAL
Source text for Eikon: ID:nASX6W1yvr
Further company coverage: LCT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Algorae Pharmaceuticals
See all newsBrief: Algorae Pharmaceuticals Executes License & Supply Agreement With Torrent Pharma
Brief: Algorae Pharmaceuticals And Zydus Enter Exclusive Commercial Agreement
Brief: Algorae Pharmaceuticals Raises A$3.9 Million At A$0.012 Per Share
Brief: Algorae Pharmaceuticals Says TGA Accepts Initial Registration Dossier For Evaluation
Brief: Algorae Pharmaceuticals Partners With Peter Maccallum Cancer Centre For Second AI-Driven Drug Synergy Screening Program